相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
Michel Komajda et al.
CARDIOVASCULAR DIABETOLOGY (2008)
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)
Erland Erdmann et al.
DIABETES CARE (2007)
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Rodrigo M. Lago et al.
LANCET (2007)
Rosiglitazone RECORD study: glucose control outcomes at 18 months
P. D. Home et al.
DIABETIC MEDICINE (2007)
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure
Henry J. Dargie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Effect of various diuretic treatments on rosiglitazone-induced fluid retention
Janaka Karalliedde et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption
YF Guan et al.
NATURE MEDICINE (2005)
Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association
RW Nesto et al.
CIRCULATION (2003)
Thiazolidinedione-associated congestive heart failure and pulmonary edema
A Kermani et al.
MAYO CLINIC PROCEEDINGS (2003)
PPARγ activation enhances cell surface ENaCα via up-regulation of SGK1 in human collecting duct cells
GZ Hong et al.
FASEB JOURNAL (2003)
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure
WHW Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Impact of glucose intolerance and insulin resistance on cardiac structure and function - Sex-related differences in the Framingham Heart Study
MK Rutter et al.
CIRCULATION (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Guidelines for the diagnosis and treatment of chronic heart failure
WJ Remme et al.
EUROPEAN HEART JOURNAL (2001)
分享论文
